Learn How Voice-Assistant Technology is Revolutionizing Clinical Trials
Pharma tech organizations are leveraging voice assistants to enable continued patient interaction and engagement, especially during clinical trials.
FREMONT, CA: Pharmaceutical organizations are seeking to implement simplicity and convenience into the process of drug development by leveraging the benefits of pharma tech. The technological revolution has introduced wearable devices and monitoring solutions to streamline medical operations and enhance the patient experience.
The medical wearables have enabled the treatment providers to monitor the patients and gather data about their condition remotely, eliminating the need for patients to visit the clinics. The organizations are also encouraging trial patients to install patient-reported outcome data apps on their smartphones instead of carrying around a second device during the study.
Voice assistant technologies such as Amazon Echo and Google Home are also on the rise. According to a prediction by Gartner, almost 30 percent of the web browsing operations will be done using voice assistants and virtual reality. The forecast is bolstered by the 130 percent increase in the sales of voice-enabled devices in the United States.
Check This Out: Top eClinical Trial Management Companies
The integration of voice assistant technology in the pharmaceutical industry can enhance engagement as well as interaction when compared to the traditional approaches. Most patients will inevitably prefer engaging and straightforward conversations over scrolling and tapping. Also, voice-enabled devices can prove a lifesaver for people not well versed in the functionality of mobile devices.
Organizations can leverage voice assistants to enable continued patient interaction and engagement, especially during trials. Even in areas such as patient training, information gathering, consent, and outcomes, voice assistant technology can be leveraged for more exceptional results.
Several organizations are investing in the development of voice assistant technology for clinical data applications. The research aims to evaluate the capabilities of the voice-enabled platforms in highly regulated environments. The benefits of the technology include its ability to engage with users of different languages with minimum intervention.
Even though the current capabilities of the voice assistant technology do not extend to data gathering and analysis, the development of the voice-enabled applications can enhance patient engagement and contribute to the success of the clinical trial. It can also be leveraged to remind the patients of their upcoming visits, arrange cab services, manage study information, secure trial consent, and create medication details, among other concerns.
By Tom Farrah, CIO & SVP, Dr Pepper Snapple Group
By George Evans, CIO, Singing River Health System
By John Kamin, EVP and CIO, Old National Bancorp
By Phil Jordan, CIO, Telefonica
By Elliot Garbus, VP-IoT Solutions Group & GM-Automotive...
By Dennis Hodges, CIO, Inteva Products
By Bill Krivoshik, SVP & CIO, Time Warner Inc.
By Gregory Morrison, SVP & CIO, Cox Enterprises
By Alberto Ruocco, CIO, American Electric Power
By Sam Lamonica, CIO & VP Information Systems, Rosendin...
By Sven Gerjets, SVP-IT, DIRECTV
By Marie Blake, EVP & CCO, BankUnited
By Lowell Gilvin, Chief Process Officer, Jabil
By Walter Carvalho, VP & Corporate CIO, Carnival Corporation
By Mary Alice Annecharico, SVP & CIO, Henry Ford Health System
By Bernd Schlotter, President of Services, Unify
By Bob Fecteau, CIO, SAIC
By Jason Alan Snyder, CTO, Momentum Worldwide
By Jim Whitehurst, CEO, Red Hat
By Marc Jones, Distinguished Engineer, IBM Cloud Infrastructure